Abbvie Inc. vs Teleflex Incorporated
ABBV vs TFX — side-by-side comparison from reported financials. ABBV leads 9, TFX leads 3 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Teleflex Incorporated
TFX · Healthcare
$125.12+0.75%Mixed
| Metric | ABBV | TFX |
|---|---|---|
| Price | $276.43 | $125.12 |
| Market cap | $488B | $5.30B |
| Revenue (TTM) | $64.4B | $6.05B |
| Revenue growth | +1.8% | -10.6% |
| Net margin | 9.8% | -16.7% |
| Free cash flow | $18.2B | $229M |
| Net cash (debt) | ($56.2B) | ($2.61B) |
| 1-year price return | +19.8% | +0.3% |
| P/E | 77.4 | 28.7 |
| P/E vs own history (cheap-side %) | 23% | 64% |
| Dividend yield | 2.45% | 1.13% |
| Return on equity | 96% | -32% |
| Altman Z-score | 2.33 | 1.93 |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 15,500 |
Full résumé-style profiles: ABBV CV · TFX CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.